Production AI systems and digital engineering for enterprise teams.Explore our work
From discovery to launch, we delivered an MVP with role-based access, audit trails, and a roadmap for HIPAA-aligned scaling.
Overview
A seed-stage HealthTech team needed to prove clinical-adjacent workflows with investors and design partners—not a slide deck. They had strong domain expertise but limited engineering bandwidth and no appetite for a throwaway prototype that would fail security questions in diligence.
Industry
HealthTech
Duration
8 weeks
Engagement
MVP delivery
Team
3 engineers + founder PM
The MVP had to demonstrate role-based access, auditability, and a credible path to HIPAA-aligned controls after seed—without building full compliance on day one. Founders needed weekly visible progress for investor updates while keeping scope ruthlessly focused on one care-coordination journey.
What we delivered
We delivered one end-to-end journey—intake, assignment, status updates, and admin oversight—with typed APIs, audit logs on sensitive actions, and documentation for post-seed hardening. Infrastructure used managed services to reduce ops burden; auth and data models were designed for tenancy expansion.
Phased delivery with clear acceptance criteria at each step.
How we deliver
Fake doors and manual steps were rejected in favor of one automated path that design partners could use daily. We cut scope weekly with the founder using a simple impact-vs-effort board.
Tangible outputs the client team owned at handoff—not slide artifacts.
Production MVP on managed cloud with CI/CD
Role-based web app and lightweight admin console
Audit logging and export for compliance conversations
Product analytics on the activation funnel
Technical diligence packet for investors
Post-seed roadmap for HIPAA and multi-tenant scale
Outcomes
Measured impact from the program—not projected estimates.
MVP live
From kickoff to design partner access
Design partners
Active within first month post-launch
Round supported
Diligence referenced MVP and architecture memo
Critical security findings
In pre-seed technical review
Technologies
What we'd do again
More proof
Explore programs in other industries—or view the full portfolio.
Tell us about your product and timeline—we'll share how we'd approach it.